EU clears first allogenic stem cell therapy – PharmaTimes
PharmaTimes |
EU clears first allogenic stem cell therapy
PharmaTimes TiGenix and Takeda's Alofisel has become the first allogeneic stem cell therapy to be approved for use across the European Union. The therapy (previously referred to as Cx601) has been cleared to treat complex perianal fistulas in adult patients with … Stem cell therapy developers unaffected by Cha Biotech debacle Stem Cell Therapy Market Status and Trend: Top Key Players, Industry Dynamics, And Regional Scope 2022 |
